Propoxyphene napsylate compared to methadone for opiate dependence

Area of Science:

• Pharmacology
• Addiction Medicine
• Clinical Trials

Background:

• Methadone maintenance therapy is a cornerstone for opioid use disorder treatment.
• Propoxyphene napsylate (PN) has been explored as an alternative or adjunct medication.
• Understanding dosage and efficacy is crucial for patient safety and treatment outcomes.

Purpose of the Study:

• To evaluate the safety and efficacy of propoxyphene napsylate (PN) in patients undergoing methadone maintenance.
• To compare PN's effects on withdrawal symptoms against various methadone dosages and placebo.
• To determine optimal dosing strategies for PN to avoid adverse effects.

Main Methods:

• A double-blind, placebo-controlled study design was employed.
• Participants included patients on methadone maintenance programs and detoxified ex-methadone patients.
• Propoxyphene napsylate was administered in single high doses and divided daily doses (800 mg/day).

Main Results:

• Single high doses of PN (over 600 mg) were associated with undesirable side effects.
• Divided doses of PN (800 mg/day) did not produce significant adverse reactions.
• PN (800 mg) did not alleviate withdrawal in patients on 20 mg methadone but was effective for those on 10 mg methadone, comparable to 10 mg methadone itself.

Conclusions:

• Propoxyphene napsylate can be safely administered in divided doses of 800 mg/day.
• PN is effective in managing mild opioid withdrawal symptoms for patients maintained on 10 mg methadone or less.
• On a mg-for-mg basis, PN is approximately 80 times more potent than methadone for symptom relief in mildly addicted patients.